|Slideshows|July 26, 2023

Research Highlights from the SNMMI 2023 Conference

Catch up on emerging research findings presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) 2023 conference.

From molecular imaging insights on obesity and kinetic modeling to bolster PET tracer quantification for cardiac amyloidosis to the role of PET imaging in de-escalating breast cancer treatment, promising research for challeging conditions was in abundance at the Society of Nuclear Imaging and Molecular Imaging (SNMMI) 2023 conference in Chicago. Review the slideshow below to check out some of the new research highlights from the conference.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

September 29th, 2026

ASTRO: What New Phase 3 Research Reveals About SBRT for Patients with Localized Prostate Cancer

For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.

September 28th, 2026

Can Brain MRI Surveillance Alone Be Advantageous in Monitoring Cognition for Patients with SCLC?

For patients with small cell lung cancer (SCLC), there was a 40 percent improvement in cognitive failure-free survival (CFFS) with brain MRI alone in comparison to the combination of brain MRI and prophylactic cranial irradiation (PCI), according to research presented at the ASTRO conference.

October 2nd, 2026

MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?

Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.

October 1st, 2026

Current Perspectives on Integrating AI into Radiology

In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.

October 1st, 2026

Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA

Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?

September 30th, 2026

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1

In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.

September 30th, 2026

Top Five Radiology Content in September 2026

Catch up on the most-well viewed radiology content in September 2026.

September 30th, 2026

FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection

The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.

Research Highlights from the SNMMI 2023 Conference

Related to this article

Trending on Diagnostic Imaging

Current Perspectives on Integrating AI into Radiology

The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1

FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection

Radiology and Building the Alzheimer’s Care Pathway of the Future

Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA